Metraipolis › archive › dc_ff98ea4f6e44
Structure-guided screening identifies Tucatinib as dual inhibitor for MCT1/2 — Europe PMC PMID:41381736
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41381736
- DOI
- 10.1038/s44319-[numero omesso]-9
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-07T17:22:42.870Z
- SHA-256 of the archived text
e51531e3a7021131e719260a3381f51b1340bda885b1c887ddfbc36a5b8c9376- Stable URL of this page
https://metraipolis.com/documento/dc_ff98ea4f6e44
How to cite
Structure-guided screening identifies Tucatinib as dual inhibitor for MCT1/2 — Europe PMC PMID:41381736 — Europe PMC (en), https://europepmc.org/article/MED/41381736 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff98ea4f6e44 (Metraipolis archive dc_ff98ea4f6e44, sha256 e51531e3a7021131e719260a3381f51b1340bda885b1c887ddfbc36a5b8c9376)
BibTeX
@misc{dcff98ea4f6e44,
title = {Structure-guided screening identifies Tucatinib as dual inhibitor for MCT1/2 — Europe PMC PMID:41381736},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41381736},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff98ea4f6e44; sha256 e51531e3a7021131e719260a3381f51b1340bda885b1c887ddfbc36a5b8c9376},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41381736. Agents can read the archived copy with the MCP tool read_document.